Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/22/2013US8563323 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
10/22/2013US8563254 Biomarkers of tumor pharmacodynamic response
10/22/2013US8563249 Receptor gene screening for detecting or diagnosing cancer
10/22/2013US8563243 Methods for affecting homology-directed DNA double stranded break repair
10/22/2013US8563072 Suspension containing hydronium stabilized colloidal silicic acid nanoparticles, formulation obtained from the said diluted suspension, powder obtained from the said de-hydrated suspension, compositions obtained from the said powder, preparation and use
10/22/2013US8563054 Anti-inflammatory agent
10/22/2013US8563053 Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis
10/22/2013US8563051 Herbal composition for weight management
10/22/2013US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/22/2013US8563040 Compositions and methods for forming and strengthening bone
10/22/2013US8563038 Formulations and methods for the controlled release of active drug substances
10/22/2013US8563034 Dual release oral tablet compositions of dexlansoprazole
10/22/2013US8563027 Drug delivery through hydrogel plugs
10/22/2013US8563025 Coatings for implantable medical devices
10/22/2013US8563019 Non-aqueous generation of chlorine dioxide
10/22/2013US8563014 Modafinil oral lyophilizate
10/22/2013US8563011 Use of low molecular weight amino alcohols in ophthalmic compositions
10/22/2013US8563009 Use of monomycolyl glycerol (MMG) as an adjuvant
10/22/2013US8563003 Method for the treatment of malignant and infectious chronic diseases
10/22/2013US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
10/22/2013US8562975 Method for stabilizing reduced coenzyme Q10 and composition therefor
10/22/2013US8562966 End-modified poly(beta-amino esters) and uses thereof
10/22/2013US8562963 Ophthalmic compositions comprising povidone-iodine
10/22/2013US8562962 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
10/22/2013US8562961 Refreshing cream foundation in gel form
10/22/2013US8562952 Methods for manipulating satiety
10/22/2013US8562951 Methods for classifying and treating physiologic brain imbalances using quantitative EEG
10/22/2013US8562945 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
10/22/2013CA2778381C Dietary supplement, and methods of use
10/22/2013CA2743030C 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/22/2013CA2707100C Morpholino compound microemulsion
10/22/2013CA2699891C Macrocyclic compounds as antiviral agents
10/22/2013CA2660991C Compositions comprising calcium citrate malate and methods for making the same
10/22/2013CA2621377C Antitumor agent
10/22/2013CA2620296C Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2613911C Crystalline forms of macrolide compounds endowed with antiinflammatory activity
10/22/2013CA2612235C Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefor
10/22/2013CA2602776C Method for treating prostate diseases based on local delivery of active substances
10/22/2013CA2601640C Use of macrolides for treating intestinal inflammation
10/22/2013CA2600507C 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
10/22/2013CA2599112C Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
10/22/2013CA2588295C Method and composition for administering an nmda receptor antagonist to a subject
10/22/2013CA2587545C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
10/22/2013CA2582045C Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
10/22/2013CA2580719C Small molecules that replace or agonize p53 function
10/22/2013CA2580150C Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/22/2013CA2577309C Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
10/22/2013CA2572872C Tissue factor production inhibitor
10/22/2013CA2566837C Anti acne skincare composition and skincare article
10/22/2013CA2551778C Imidazo[1,2-c]pyrimidinylacetic acid derivatives
10/22/2013CA2550642C Oligonucleotide compound and method for treating nidovirus infections
10/22/2013CA2538146C Pyridomorphinans, pyridazinomorphinans and use thereof
10/22/2013CA2535813C Pantoprazole preparation for injection
10/22/2013CA2528179C Piperidinyl prostaglandin e analogs
10/22/2013CA2524569C A method of regulating gene expression
10/22/2013CA2473526C Polyalkylene polymer compounds and uses thereof
10/22/2013CA2460074C Medical devices containing rapamycin analogs
10/22/2013CA2457488C Antimicrobial agent
10/22/2013CA2455129C Improvements in the extraction of pharmaceutically active components from plant materials
10/22/2013CA2429665C Method of making particles for use in a pharmaceutical composition
10/22/2013CA2424001C Oral preparations with favorable disintegration characteristics
10/22/2013CA2359926C Antagonists of hmg1 for treating inflammatory conditions
10/18/2013DE202010018054U1 Zusammensetzung zur Linderung von Gelenkschmerzen Composition for the relief of joint pain
10/17/2013WO2013155528A2 Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels
10/17/2013WO2013155506A1 Novel compositions and methods
10/17/2013WO2013155505A1 Organic compounds
10/17/2013WO2013155504A1 Novel methods
10/17/2013WO2013155485A2 Method of using cyclodextrin
10/17/2013WO2013155478A1 Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
10/17/2013WO2013155465A1 Substituted xanthine derivatives
10/17/2013WO2013155464A1 Combination therapy for treating cancer
10/17/2013WO2013155448A1 Disaccharide synthetic lipid compounds and uses thereof
10/17/2013WO2013155447A1 Tiki inhibitors
10/17/2013WO2013155422A1 Methods of treating alopecia and acne
10/17/2013WO2013155406A1 Contragestion and treating inflammation by modulating sodium channel activity in the epithelium
10/17/2013WO2013155387A1 Pharmaceutical formulations of indibulin and uses thereof
10/17/2013WO2013155385A1 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
10/17/2013WO2013155381A1 Treatment for microbe-induced inflammatory responses in the eye
10/17/2013WO2013155375A1 Enhanced anti-influenza agents conjugated with anti-inflammatory activity
10/17/2013WO2013155374A2 Cholesterol efflux assay probe formulations, methods of making and using
10/17/2013WO2013155347A1 Bruton's tyrosine kinase inhibitors for hematopoietic mobilization
10/17/2013WO2013155341A1 Methods and compositions for treating ewings sarcoma family of tumors
10/17/2013WO2013155317A1 Salt form of a human hi stone methyltransf erase ezh2 inhibitor
10/17/2013WO2013155262A2 Methods for improving resistance to skeletal muscle fatigue
10/17/2013WO2013155223A1 Compositions and methods for treating cancer
10/17/2013WO2013155218A1 Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
10/17/2013WO2013155142A2 Method of modifying spermatogenesis, spermiogenesis and/or fertility in mammals
10/17/2013WO2013155134A1 Non-immunogenic delivery vehicle for beta-, gamma-, and delta- tocopherols and methods of using and making same
10/17/2013WO2013155123A1 Compositions and methods for treating otitis media and other conditions with inhibitors of cyld
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154794A1 Trans 10 : ci s 12 isomer of conjugated linoleic acid as a therapeutic and preventative agent for pregnancy induced hypertension or preeclampsia
10/17/2013WO2013154793A1 F2 derivatives as antibacterial agents
10/17/2013WO2013154778A1 Host targeted inhibitors of dengue virus and other viruses
10/17/2013WO2013154766A1 Microrna control of ldl receptor pathway
10/17/2013WO2013154759A1 Benzoxaborole compounds and uses thereof
10/17/2013WO2013154735A1 Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells
10/17/2013WO2013154725A1 Prebiotic compositions and methods of use
10/17/2013WO2013154712A1 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
1 ... 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 ... 7860